Staar Surgical Co. today announced that its board of directors has appointed Chief Operating Officer and President Warren Foust and Chief Financial Officer Deborah Andrews as interim co-chief executives.
Last month, Stephen Farrell stepped down as CEO after a board restructuring that resulted in the removal of Farrell and Chair Elizabeth Yeu.
The changed followed Staar terminating its proposed $1.6 billion sale to Alcon after failing to get enough votes to approve the deal at a special stockholder meeting held on Jan. 6.
Staar said that the search committee has initiated a global search for its next CEO, including both internal and external candidates.
Shares in Staar were down 3.6% to $18.26 apiece and a $901 million market cap (Nasdaq: STAA).
